Q17QD6
Gene name |
TMEFF2 |
Protein name |
Tomoregulin-2 |
Names |
TR-2, Transmembrane protein with EGF-like and two follistatin-like domains |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:538354 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q17QD6
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q17QD6-F1 | Predicted | AlphaFoldDB |
22 variants for Q17QD6
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs460895239 | 5 | E>G | No | EVA | |
| rs460335595 | 10 | C>W | No | EVA | |
| rs438559153 | 12 | S>T | No | EVA | |
| rs471379915 | 14 | T>R | No | EVA | |
| rs462702241 | 17 | E>* | No | EVA | |
| rs480247898 | 18 | G>C | No | EVA | |
| rs480247898 | 18 | G>S | No | EVA | |
| rs454918921 | 28 | M>R | No | EVA | |
| rs436524252 | 43 | T>P | No | EVA | |
| rs432566700 | 51 | P>R | No | EVA | |
| rs454272815 | 51 | P>T | No | EVA | |
| rs465522488 | 55 | N>D | No | EVA | |
| rs450418336 | 55 | N>K | No | EVA | |
| rs481400725 | 178 | V>G | No | EVA | |
| rs448236438 | 178 | V>I | No | EVA | |
| rs440374960 | 179 | W>S | No | EVA | |
| rs483147536 | 202 | Y>S | No | EVA | |
| rs448804868 | 226 | R>Q | No | EVA | |
| rs522246922 | 270 | N>S | No | EVA | |
| rs476947300 | 299 | H>P | No | EVA | |
| rs525754313 | 323 | A>P | No | EVA | |
| rs518270832 | 331 | I>M | No | EVA |
No associated diseases with Q17QD6
3 regional properties for Q17QD6
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | EGF-like domain | 261 - 301 | IPR000742 |
| domain | Kazal domain | 90 - 137 | IPR002350-1 |
| domain | Kazal domain | 181 - 229 | IPR002350-2 |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| cell differentiation | The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
| negative regulation of cell migration | Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration. |
| negative regulation of integrin biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins. |
| negative regulation of stress fiber assembly | Any process that stops, prevents, or reduces the frequency, rate or extent of the assembly a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts. |
| wound healing, spreading of cells | The migration of a cell along or through a wound gap that contributes to the reestablishment of a continuous surface. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MVLWESPRQC | SSWTLCEGFC | WLLLLPVMLL | IVARPVKLAA | FPTSLSDCQT | PTGWNCSGYD |
| 70 | 80 | 90 | 100 | 110 | 120 |
| DRENDLFLCD | TNTCKFDGEC | LRIGDTVTCV | CQFKCNSDYV | PVCGSNGESY | QNECYLRQAA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| CKQQSEILVV | SEGSCATDAG | SGSGDGVHEG | SGETSQKETS | TCDICQFGAE | CDEDAEDVWC |
| 190 | 200 | 210 | 220 | 230 | 240 |
| VCNIDCSQTN | FNPLCASDGK | SYDNACQIKE | ASCQKQEKIE | VMSLGRCQDN | TTTTTKSEDG |
| 250 | 260 | 270 | 280 | 290 | 300 |
| HYARTDFAEN | ANKLEESARE | HHIPCPEHYN | GFCMHGKCEH | SINMQEPSCR | CDAGYTGQHC |
| 310 | 320 | 330 | 340 | 350 | 360 |
| EKKDYSVLYV | VPGPVRFQYV | LIAAVIGTIQ | IAVICVVVLC | ITRKCPRSNR | IHRQKQNTGH |
| 370 | |||||
| YSSDNTTRAS | TRLI |